Targeted therapy is an advanced cancer treatment that uses drugs to target specific proteins and genes found in cancer cells and related cells. These drugs help prevent cancer from spreading to other parts of the body.

The robotic maneuverability of the CyberKnife S7 system enables doctors to deliver highly personalized treatments. CyberKnife S7 clinicians at Valentis can select various angles targeting the tumor with a high dose of radiation from every conceivable angle.

The CyberKnife S7 employs a sophisticated 6D image guidance system to track and adjust treatment in response to any movement of the patient or tumor.

Depending on the type of tumor, patients typically require one to five CyberKnife S7 treatments, which typically last less than 30 minutes, whereas other radiation systems require dozens of treatments spread out over several weeks.

The CyberKnife S7 is a fully integrated closed-loop system, unlike other gantry-based linear accelerators. Each function collaborates to provide the safest possible patient experience.

Depending on the type of tumor, patients typically require one to five CyberKnife S7 treatments, which typically last less than 30 minutes, whereas other radiation systems require dozens of treatments spread out over several weeks.

Precise treatment of spinal tumors with sub-millimeter accuracy, protecting the spinal cord and surrounding critical structures.

Non-invasive treatment option for prostate cancer with minimal side effects and excellent outcomes.

Stereotactic radiotherapy can deliver highly focused, high-dose treatment to selected pancreatic tumours, offering a non-invasive option to improve local control, relieve symptoms, and potentially downstage disease. It is typically used as part of a multidisciplinary plan alongside chemotherapy or surgery when appropriate, with careful planning to protect adjacent organs such as the stomach and intestines.

Effective treatment for liver tumors including hepatocellular carcinoma and liver metastases.